# European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes

> **NCT01239589** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1280 (actual)

## Conditions studied

- Acute Bipolar Manic Episode

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01239589
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1280 (ACTUAL)
- **Last updated:** 2011-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239589, "European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01239589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*